# Optimal Dose of Alfentanil for Removal of Supreme Laryngeal Mask Airway During Emergence From Desflurane Anaesthesia

> **NCT01371968** · NA · COMPLETED · sponsor: **University of Malaya** · enrollment: 30 (actual)

## Conditions studied

- Airway Response

## Interventions

- **DRUG:** alfentanil

## Key facts

- **NCT ID:** NCT01371968
- **Lead sponsor:** University of Malaya
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-08
- **Final completion:** 2011-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01371968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01371968, "Optimal Dose of Alfentanil for Removal of Supreme Laryngeal Mask Airway During Emergence From Desflurane Anaesthesia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01371968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*